The use of a noninvasive hemoglobin monitor for determining fluid distribution and elimination in pediatric patients undergoing minor surgery

Journal of Clinical Monitoring and Computing

Volumn 29, Issue 1, 2015, Pages 41-46

  Lian, Qingquan ^a   Li, Husong ^b   Zeng, Ruifeng ^a   Lang, Junhui ^a   Shangguan, Wangning ^a   Liu, Huacheng ^a   Wang, Benfu ^a   Rodhe, Peter M ^c   Svensen, Christer H ^c  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Fluid balance; Fluid distribution; Fluid elimination; Fluid therapy; Fluids; Pharmacokinetics

Indexed keywords

ANESTHESIOLOGY; DILUTION; FLUIDS; HEMOGLOBIN; NONINVASIVE MEDICAL PROCEDURES; PATIENT MONITORING; PEDIATRICS; PHARMACOKINETICS; SURGERY;

FLUID DISTRIBUTION; FLUID THERAPY; GENERAL ANESTHESIAS; INDIVIDUAL VARIABILITY; MEAN RESIDENCE TIME; MEASUREMENT TECHNIQUES; NONINVASIVE MEASUREMENTS; SURGICAL PROCEDURES;

RESIDENCE TIME DISTRIBUTION;

CARBON MONOXIDE; HEMOGLOBIN; HETASTARCH DERIVATIVE;

CHEMISTRY; CHILD; GENERAL ANESTHESIA; HUMAN; INFANT; KINETICS; MINOR SURGERY; OXIMETRY; PATIENT MONITORING; PEDIATRICS; PHYSIOLOGIC MONITORING; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY; TIME;

ANESTHESIA, GENERAL; CARBON MONOXIDE; CHILD; CHILD, PRESCHOOL; HEMOGLOBINS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INFANT; KINETICS; MINOR SURGICAL PROCEDURES; MONITORING, INTRAOPERATIVE; MONITORING, PHYSIOLOGIC; OXIMETRY; PEDIATRICS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84922337662     PISSN: 13871307     EISSN: 15732614     Source Type: Journal    
DOI: 10.1007/s10877-014-9566-6     Document Type: Article

References (21)

1. Schwarz U. Intraoperative fluid therapy in infants and young children. Anaesthesist. 1999;48(1):41–50.
2. Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol. 2008;25(6):437–45.
3. Hahn RG. Volume kinetics for infusion fluids. Anesthesiology. 2009;113:470–81.
4. Shamir MY, Avramovich A, Smaka T. The current status of continuous noninvasive measurement of total, carboxy, and methemoglobin concentration. Anesthesia Analgesia. 2012;114(5):972–8.
5. Frasca D, Dahyot-Fizelier C, Catherine K, Levrat Q, Debaene B, Mimoz O. Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients. Crit Care Med. 2011;39(10):2277–82.
6. Hahn RG, Li Y, Zdolsek J. Non-invasive monitoring of blood haemoglobin for analysis of fluid volume kinetics. Acta Anaesthesiol Scand. 2010;54(10):1233–40.
7. Park YH, Lee JH, Song HG, Byon HJ, Kim HS, Kim JT. The accuracy of noninvasive hemoglobin monitoring using the radical-7 pulse CO-oximeter in children undergoing neurosurgery. Anesth Analg. 2012;115(6):1302–7.
8. Bergek C, Zdolsek JH, Hahn RG. Accuracy of noninvasive haemoglobin measurement by pulse oximetry depends on the type of infusion fluid. Eur J Anaesthesiol. 2012;29(12):586–92.
9. Nguyen BV, Vincent JL, Nowak E, Coat M, Paleiron N, Gouny P, et al. The accuracy of noninvasive hemoglobin measurement by multiwavelength pulse oximetry after cardiac surgery. Anesth Analg. 2011;113(5):1052–7.
10. Svensen C, Olsson J, Rodhe P, Boersheim E, Aarsland A, Hahn RG. Arteriovenous differences in plasma dilution and the kinetics of lactated ringer′s solution. Anesth Analg. 2009;108:128–33.
11. Karol MD. Mean residence time and the meaning of AUMC/AUC. Biopharm Drug Dispos. 1990;11(2):179–81.
12. ®) and laboratory haemoglobin measurements in obstetric patients. Anaesthesia. 2013;68(1):40–5.
13. Miller RD, Ward TA, Shiboski SC, Cohen NH. A comparison of three methods of hemoglobin monitoring in patients undergoing spine surgery. Anesth Analg. 2011;112(4):858–63.
14. Macknet MR, Allard M, Applegate RL 2nd, Rook J. The accuracy of noninvasive and continuous total hemoglobin measurement by pulse CO-Oximetry in human subjects undergoing hemodilution. Anesth Analg. 2010;111:1424–6.
15. Morey TE, Gravenstein N, Rice MJ. Let’s think clinically instead of mathematically about device accuracy. Anesth Analg. 2011;113(1):89–91.
16. Sjöstrand F, Rodhe P, Berglund E, Lundström N, Svensen C. The use of a noninvasive hemoglobin monitor for volume kinetic analysis in an emergency room setting. Anesth Analg. 2013;116(2):337–42.
17. Paul M, Dueck M, Joachim Herrmann H, Holzki J. A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) versus lactated Ringer’s solution. Paediatr Anaesth. 2003;13(7):603–8.
18. Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand. 2006;50(1):108–11.
19. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.4 versus ringer’s acetate in severe sepsis. N Eng J Med. 2012;367:124–34.
20. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11.
21. Akkucuk FG, Kanbak M, Ayhan B, Celebioglu B, Aypar U, et al. The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Renal Fail. 2013;35(2):210–5